Literature DB >> 19418622

Memory T cells in GVHD and GVL.

Britt E Anderson1, Hong Zheng, Patricia A Taylor, Catherine Matte-Martone, Jeniffer M McNiff, Dhanpat Jain, Anthony J Demetris, Angela Panoskaltsis-Mortari, Ann Ager, Bruce R Blazar, Mark J Shlomchik, Warren D Shlomchik.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19418622

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  9 in total

1.  SOCS3 regulates graft-versus-host disease.

Authors:  Geoffrey R Hill; Rachel D Kuns; Neil C Raffelt; Alistair L J Don; Stuart D Olver; Kate A Markey; Yana A Wilson; Joel Tocker; Warren S Alexander; Andrew D Clouston; Andrew W Roberts; Kelli P A MacDonald
Journal:  Blood       Date:  2010-04-30       Impact factor: 22.113

Review 2.  T cell optimization for graft-versus-leukemia responses.

Authors:  Melinda A Biernacki; Vipul S Sheth; Marie Bleakley
Journal:  JCI Insight       Date:  2020-05-07

3.  Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.

Authors:  J Joseph Melenhorst; Phillip Scheinberg; Ann Williams; David R Ambrozak; Keyvan Keyvanfar; Melody Smith; J Philip McCoy; Nancy F Hensel; Daniel C Douek; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-06       Impact factor: 5.742

Review 4.  Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity.

Authors:  Qingxiao Song; Ubaydah Nasri; Ryotaro Nakamura; Paul J Martin; Defu Zeng
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

5.  Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.

Authors:  Marie Bleakley; Shelly Heimfeld; Lori A Jones; Cameron Turtle; Diane Krause; Stanley R Riddell; Warren Shlomchik
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-11       Impact factor: 5.742

Review 6.  Relapse after allogeneic hematopoietic cell therapy.

Authors:  Marcel R M van den Brink; David L Porter; Sergio Giralt; Sydney X Lu; Robert R Jenq; Alan Hanash; Michael R Bishop
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-24       Impact factor: 5.742

Review 7.  Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.

Authors:  Anne M Dickinson; Jean Norden; Shuang Li; Ilona Hromadnikova; Christoph Schmid; Helga Schmetzer; Hans Jochem-Kolb
Journal:  Front Immunol       Date:  2017-06-07       Impact factor: 7.561

8.  Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.

Authors:  Robson G Dossa; Tanya Cunningham; Daniel Sommermeyer; Indira Medina-Rodriguez; Melinda A Biernacki; Kimberly Foster; Marie Bleakley
Journal:  Blood       Date:  2017-10-19       Impact factor: 25.476

9.  Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use.

Authors:  Huijie Jia; Jing Cui; Xiaolong Jia; Jingjing Zhao; Yuchen Feng; Peijuan Zhao; Dan Zang; Jian Yu; Tiesuo Zhao; Hui Wang; Kailin Xu
Journal:  Mol Med Rep       Date:  2017-10-19       Impact factor: 2.952
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.